NCT05933304View on ClinicalTrials.gov

A Study of the Effectiveness of Moderna COVID-19 Vaccine

CompletedOBSERVATIONAL
Enrollment

927,004

Participants

Timeline

Start Date

December 18, 2020

Primary Completion Date

November 17, 2023

Study Completion Date

November 17, 2023

Conditions
SARS-CoV-2COVID-19
Trial Locations (1)

91101

Kaiser Permanente Southern California, Pasadena

All Listed Sponsors
lead

ModernaTX, Inc.

INDUSTRY

NCT05933304 - A Study of the Effectiveness of Moderna COVID-19 Vaccine | Biotech Hunter | Biotech Hunter